Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$TEAM, $DRD, $HZO, $NEWR, $NOW, $PSTI, $SPLK

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is our list for Wednesday, 15 April, as follows:

Atlassian Corp. PLC (NASDAQ:TEAM) was reiterated as Buy with a 162 price target at SunTrust Robinson Humphrey.

DRDGold Ltd. (NYSE:DRD): gold miners are benefiting greatly from gold prices. Shares recently closed at 8.81 and have a consensus price target of 9.25

MarineMax Inc. (NYSE:HZO) was reiterated as Buy and its price target was raised to 14 from 12 at SunTrust Robinson Humphrey.

New Relic Inc. (NYSE:NEWR) was maintained as Buy but the price target was cut to 75 from 85 at SunTrust Robinson Humphrey.

Pluristem Therapeutics Inc. (NASDAQ:PSTI) was reiterated as Buy with a 12 price target at Dawson James, which noted that the FDA cleared its compassionate use using PLX cells to treat its first COVID-19 patient in the United States.

ServiceNow Inc. (NYSE:NOW) was maintained as Buy but the price target was cut to 350 from 380 at SunTrust Robinson Humphrey.

Splunk Inc. (NASDAQ:SPLK) was maintained as Buy but the price target was cut to 180 from 190 at SunTrust Robinson Humphrey

Have a healthy day, Keep the Faith!

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.